Cardiotonic Agents

"Cardiotonic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).

Descriptor ID	D002316
MeSH Number(s)	D27.505.954.411.222 D27.720.799.080
Concept/Terms	Cardiotonic Agents Cardiotonic Agents Cardiac Stimulants Inotropic Agents, Positive Cardiac Cardiotonic Drugs Cardiotonics Myocardial Stimulants Cardioprotective Agents

Below are MeSH descriptors whose meaning is more general than "Cardiotonic Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Cardiovascular Agents [D27.505.954.411]
Cardiotonic Agents [D27.505.954.411.222]
Specialty Uses of Chemicals [D27.720]
Protective Agents [D27.720.799]
Cardiotonic Agents [D27.720.799.080]

Below are MeSH descriptors whose meaning is more specific than "Cardiotonic Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cardiotonic Agents" by people in this website by year, and whether "Cardiotonic Agents" was a major or minor topic of these publications.

Bar chart showing 27 publications over 16 distinct years, with a maximum of 4 publications in 2004

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	1	2
2000	1	0	1
2002	1	0	1
2003	1	1	2
2004	3	1	4
2005	1	0	1
2006	2	0	2
2008	1	1	2
2009	1	1	2
2012	2	0	2
2013	1	0	1
2015	1	1	2
2016	1	1	2
2018	1	0	1
2019	0	1	1
2021	0	1	1

Below are the most recent publications written about "Cardiotonic Agents" by people in Profiles.

Stewart JM, Warsy IA, Visintainer P, Terilli C, Medow MS. Supine Parasympathetic Withdrawal and Upright Sympathetic Activation Underly Abnormalities of the Baroreflex in Postural Tachycardia Syndrome: Effects of Pyridostigmine and Digoxin. Hypertension. 2021 04; 77(4):1234-1244.

View in: PubMed
Carreiro S, Miller S, Wang B, Wax P, Campleman S, Manini AF. Clinical predictors of adverse cardiovascular events for acute pediatric drug exposures. Clin Toxicol (Phila). 2020 03; 58(3):183-189.

View in: PubMed
Rowin EJ, Maron BJ, Abt P, Kiernan MS, Vest A, Costantino F, Maron MS, DeNofrio D. Impact of Advanced Therapies for Improving Survival to Heart Transplant in Patients with Hypertrophic Cardiomyopathy. Am J Cardiol. 2018 04 15; 121(8):986-996.

View in: PubMed
Al-Khateeb M, Qureshi WT, Odeh R, Ahmed AM, Sakr S, Elshawi R, Bdeir MB, Al-Mallah MH. The impact of digoxin on mortality in patients with chronic systolic heart failure: A propensity-matched cohort study. Int J Cardiol. 2017 Feb 01; 228:214-218.

View in: PubMed
Dharmarajan K, Strait KM, Tinetti ME, Lagu T, Lindenauer PK, Lynn J, Krukas MR, Ernst FR, Li SX, Krumholz HM. Treatment for Multiple Acute Cardiopulmonary Conditions in Older Adults Hospitalized with Pneumonia, Chronic Obstructive Pulmonary Disease, or Heart Failure. J Am Geriatr Soc. 2016 08; 64(8):1574-82.

View in: PubMed
Coles AH, Tisminetzky M, Yarzebski J, Lessard D, Gore JM, Darling CE, Goldberg RJ. Magnitude of and Prognostic Factors Associated With 1-Year Mortality After Hospital Discharge for Acute Decompensated Heart Failure Based on Ejection Fraction Findings. J Am Heart Assoc. 2015 Dec 23; 4(12).

View in: PubMed
Temtanakitpaisan Y, Kilari S, Damrongwatanasuk R. Use of digoxin in chronic systolic heart failure in current era. Am J Med. 2015 Jan; 128(1):e17.

View in: PubMed
Goldberg RJ, Gurwitz JH, Saczynski JS, Hsu G, McManus DD, Magid DJ, Smith DH, Go AS. Comparison of medication practices in patients with heart failure and preserved versus those with reduced ejection fraction (from the Cardiovascular Research Network [CVRN]). Am J Cardiol. 2013 May 01; 111(9):1324-9.

View in: PubMed
Chen-Scarabelli C, Saravolatz L, Murad Y, Shieh WS, Qureshi W, Di Rezze J, Abrencillo R, Gardin T, Gidwani UK, Saravolatz L, Faggian G, Scarabelli TM. A critical review of the use of carvedilol in ischemic heart disease. Am J Cardiovasc Drugs. 2012 Dec 01; 12(6):391-401.

View in: PubMed
Raghunathan K, Bloomstone JA, McGee WT. Cardiac output measured with both esophageal Doppler device and Vigileo-FloTrac device. Anesth Analg. 2012 May; 114(5):1141-2; author reply 1142.

View in: PubMed

People

Explore

Similar Concepts

Top Journals